Next-generation POC Devices for Western and Global Health Markets

Video   Jul 21, 2015

 



About the Speaker
Samuel Sia is an Associate Professor in the Department of Biomedical Engineering at Columbia University. His lab focuses on using microfluidics for global health diagnostics and for 3D tissue biology. He is a founder of Claros Diagnostics, a venture capital-backed company developing diagnostics products which was acquired by Opko Health, and Harlem Biospace, New York City's first life-science incubatorAbstract
Portable diagnostic devices have a tremendous potential for revolutionizing personal health.  In U.S. and Europe, patients and consumers can have greater access to traditionally complex diagnostics, and in developing countries, mobile diagnostics provides immediate diagnosis in the field.  We will discuss our lab's current efforts in these areas, in conjunction with partners in industry, public health, and local governments.  Our tests span a variety of technologies, and target HIV, sexually transmitted diseases, and chronic diseases.

 
 

Recommended Videos

The Evolution of PCR

Video

Launching the first FDA-approved PCR test in 1993, Roche Molecular Diagnostics has not only defined and refined PCR, but it has remained the clear leader of this technology.

WATCH NOW

Single Cell Analysis in Diagnostics

Video

Professor Ulf Landegren of Uppsala University talks single cell analysis.

WATCH NOW

Marching for Science in London

Video

Hear from the organisers, speakers, and protesters at London's March for Science.

WATCH NOW

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE